Loading...
XJPX
8086
Market cap1.51bUSD
Dec 05, Last price  
1,437.50JPY
1D
-1.07%
1Q
-8.00%
Jan 2017
12.48%
Name

Nipro Corp

Chart & Performance

D1W1MN
XJPX:8086 chart
P/E
45.84
P/S
0.36
EPS
31.36
Div Yield, %
1.88%
Shrs. gr., 5y
2.45%
Rev. gr., 5y
7.81%
Revenues
644.59b
+9.85%
206,801,000,000184,362,000,000172,113,000,000175,944,000,000177,829,000,000195,942,000,000212,013,000,000241,020,000,000300,752,000,000325,084,000,000366,650,000,000359,699,000,000395,397,000,000426,399,000,000442,516,000,000455,559,000,000494,789,000,000545,199,000,000586,785,000,000644,586,000,000
Net income
5.11b
-53.97%
4,512,000,0008,555,000,0004,454,000,0004,530,000,0007,252,000,0002,455,000,0004,585,000,00010,231,000,0002,861,000,00012,470,000,00019,718,000,00011,346,000,00011,829,000,00012,136,000,000-12,281,000,00014,209,000,00013,455,000,0004,574,000,00011,109,000,0005,114,000,000
CFO
68.46b
-6.14%
6,701,000,00014,488,000,0009,675,000,00018,851,000,00026,240,000,00021,799,000,00015,486,000,00022,593,000,00021,552,000,00027,981,000,00029,934,000,00033,472,000,00041,046,000,00041,362,000,00037,246,000,00066,093,000,00068,214,000,00010,395,000,00072,936,000,00068,461,000,000
Dividend
Mar 30, 202618 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations. The company's Pharma Packaging business offers glass vials, ampoules, syringes, and cartridges; glass tubes; glass forming machinery; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.
IPO date
Feb 01, 1987
Employees
38,770
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT